Patients who use drugs that have the potential contaminant should talk to their health care providers before they decide if they want to stop taking the medication because of a concern about a cancer risk, the FDA said
Due to the retrospective nature of the data, other confounding factors may have affected the results as well
Navigating GLP-1s and Pancreatitis: What You Need to Know In the rapidly evolving landscape of weight management and diabetes care, GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have become game-changers
The drug, originally developed by Zealand Pharma, has been available for several years in Europe under the brand name Lyxumia, but Sanofi has opted to market it as Adlyxin in the US
, this is a great place to begin